Obstetrics and Gynecology

Medicine & Life Sciences

1. Adenocarcinoma 13%
2. Adrenergic Agents 15%
3. Assisted Reproductive Techniques 12%
4. Biomarkers 10%
5. Biopsy 16%
6. Breast Neoplasms 18%
7. Carboplatin 11%
8. Carcinoma 40%
9. Cell Biology 13%
10. Cervix Uteri 39%
11. Chorionic Gonadotropin 14%
12. Cisplatin 24%
13. Cohort Studies 11%
14. Collagen 9%
15. Colposcopy 14%
16. Condylomata Acuminata 11%
17. Confidence Intervals 14%
18. Doxorubicin 13%
19. Drug Therapy 18%
20. Embryo Transfer 10%
21. Embryonic Structures 9%
22. Endometrial Neoplasms 35%
23. Endometriosis 39%
24. Endometrium 9%
25. Epithelium 9%
26. Etoposide 9%
27. Fallopian Tubes 20%
28. Fertility 11%
29. Fertilization in Vitro 9%
30. Fetal Development 17%
31. Fetal Growth Retardation 59%
32. Fetal Heart Rate 11%
33. Fetus 74%
34. Fluorescence 27%
35. Fluorescence Spectrometry 25%
36. fms Genes 27%
37. Folic Acid 12%
38. Gene Expression 9%
39. Gestational Trophoblastic Disease 9%
40. Glucose 32%
41. Growth 15%
42. Health 10%
43. Hispanic Americans 10%
44. Hypoglycemia 11%
45. Hypoxia 13%
46. Hysterectomy 33%
47. In Vitro Techniques 9%
48. Infertility 21%
49. Insulin 25%
50. Insulin Secretion 36%
51. Islets of Langerhans 18%
52. Laparoscopy 9%
53. Laparotomy 11%
54. Lasers 9%
55. Live Birth 10%
56. Lymph Node Excision 12%
57. Lymph Nodes 9%
58. Macrophage Colony-Stimulating Factor 43%
59. Macrophage Colony-Stimulating Factor Receptors 11%
60. Messenger RNA 18%
61. Mexico 10%
62. Mothers 21%
63. Neoplasm Metastasis 16%
64. Neoplasms 45%
65. Norepinephrine 12%
66. Nutrients 9%
67. Obstetrics 11%
68. Odds Ratio 11%
69. Optical Coherence Tomography 14%
70. Optical Imaging 16%
71. Ovarian Epithelial Carcinoma 26%
72. Ovarian Neoplasms 100%
73. Ovary 26%
74. Oxygen 10%
75. Paclitaxel 9%
76. Papanicolaou Test 9%
77. Papillary Carcinoma 14%
78. Papillomavirus Infections 16%
79. Pelvic Exenteration 23%
80. Placental Insufficiency 29%
81. Placental Lactogen 10%
82. Platinum 15%
83. Pregnancy 44%
84. Pregnancy Outcome 10%
85. Progression-Free Survival 9%
86. Prospective Studies 11%
87. Proteins 10%
88. Radiotherapy 19%
89. Recurrence 13%
90. Serum 9%
91. Sheep 73%
92. Squamous Cell Carcinoma 18%
93. Survival 23%
94. Therapeutics 20%
95. Umbilicus 15%
96. Uterine Cervical Dysplasia 17%
97. Uterine Cervical Neoplasms 60%
98. Uterus 9%
99. Vulva 9%
100. Women's Health 10%